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ABSTRACT
PCR with broad-range primers for prokaryotic
16S rRNA genes was used to identify bacterial
DNA in tissue from patients undergoing valve
replacements following a previous episode of
infective endocarditis (IE). Of eight valves inves-
tigated, bacterial DNA was detected in three from
patients for whom IE had been treated by antibi-
otic therapy 5, 12 and 18 months previously. The
demonstration of bacterial DNA within resected
heart valves suggests either recurrence of infec-
tion, treatment failure or the persistence of bac-
terial debris within the cardiac vegetation. There
may also be implications for routine use of PCR in
the diagnosis of infection.
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Diagnosis of infective endocarditis (IE) is based
on fulﬁlment of the Duke criteria, principally
positive blood cultures and abnormal echocardi-
ography [1]. However, blood cultures remain
sterile for a signiﬁcant percentage (up to 31%)
of suspected IE patients [2]. This may be caused
by previous antibiotic therapy or infection with a
non-culturable microorganism. Achieving a ﬁrm
diagnosis can be difﬁcult without recovery of the
infecting microorganism, and directed antimicro-
bial therapy cannot be instigated. Ampliﬁcation of
bacterial 16S rRNA genes present within excised
cardiac tissue by PCR, and subsequent sequen-
cing of the PCR product, has proved to be a useful
technique for identifying the infecting microor-
ganism, particularly in those patients for whom
blood cultures were negative [3–6].
In a previous study, it was possible to success-
fully identify bacterial DNA present in valve
material excised from patients with active IE by
PCR ampliﬁcation of 16S rRNA genes and
sequence analysis [7]. In the present study, the
same PCR technology was used to investigate
heart valves excised from eight patients undergo-
ing valve replacement following episodes of IE
treated several months or years previously (M:F
ratio of 6:2; mean age of 62 years; age range
36–91 years). All patients had completed the
appropriate course of antibiotic therapy, as
recommended by the Working Party of the British
Society for Antimicrobial Chemotherapy [8] and
the American Heart Association [9], and treat-
ment was considered to be successful.
Excised valve tissue was homogenised and the
supernatant used to obtain DNA for use as a
template for PCR ampliﬁcation [7]. Broad-range
oligonucleotide primers DG74 and RW01 [4,10],
which correspond to highly conserved regions
ﬂanking more variable areas of the bacterial 16S
rRNA gene, were used with a 30-cycle PCR
protocol to amplify any prokaryotic DNA present
within the valves. A negative control of glass
beads and PCR grade water (as used to homo-
genise tissues), and a positive control of whole
Staphylococcus epidermidis cells, were included
with every ampliﬁcation reaction. Subsequent
sequencing of the PCR product (c. 371 bp in size)
allowed identiﬁcation of the infecting microor-
ganism by comparison with the GenBank nucleic
acid sequence database using the BlastN algo-
rithm. Ethics Committee approval was obtained
for investigation of tissue samples.
Work in the previous study demonstrated that
the PCR results obtained from the excised tissues
of acute phase IE patients’ samples correlated
with those obtained by standard blood cultures
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[7]. Of the eight resected valves investigated
in the current study, a bacterial genus
corresponding with that shown by direct culture
to have caused the previous episode of IE was
identiﬁed in two tissue samples (Table 1), while
DNA of a viridans Streptococcus was identiﬁed in
the valve excised from a blood culture-negative,
IE-deﬁnite patient. Previous experience with
PCR on almost 100 valves has shown no false-
positive reactions [7], indicating that this viri-
dans Streptococcus was the cause of the original
infection. The ﬁve PCR-negative valve tissues
were excised from patients who had completed
antimicrobial therapy > 2 years before surgery,
except for one patient (3 months previously;
Table 1).
The persistence of bacterial DNA within three
valves for up to 18 months after the completion of
antimicrobial treatment was intriguing. One pos-
sibility is that patients had recurrent IE. None had
any clinical evidence of infection at the time of
surgery; e.g., C-reactive protein levels were not
elevated. Additionally, retrospective analysis of
clinical records indicated that these patients had
received appropriate antibiotic therapy at the
time of diagnosis: the 62-year-old-male (Table 1)
received benzylpenicillin for 6 weeks, with
gentamicin for the ﬁrst 2 weeks of therapy; the
58-year-old male received benzylpenicillin and
ﬂucloxacillin for 6 weeks, with gentamicin for the
ﬁrst 2 weeks; the 73-year-old male received ben-
zylpenicillin for 6 weeks, and gentamicin for
2 weeks, with intravenous ﬂucloxacillin being
added for the ﬁnal 3 weeks of treatment. A
second possibility is that the initial infection had
not been resolved completely and bacteria
remained within the tissue in a viable but non-
culturable state (all valves were culture-negative
using a standard microbiological method). It has
been reported that IE can reoccur months after the
initial infectious episode [11], indicating that
bacteria can remain viable within tissues for
substantial periods without signs of infection.
As already stated, there was no evidence to
suggest that antimicrobial therapy was sub-opti-
mal or that infection was not resolved with
antibiotic treatment. A third possibility is that
antimicrobial therapy had been successful and
that PCR was detecting DNA in the debris of
killed bacteria, for example in healed cardiac
vegetations. Though previous studies have shown
the clearance of pathogen DNA to be rapid
following treatment [12,13], Noordhoek et al.
[14] reported the persistence of Treponema palli-
dum DNA in cerebrospinal ﬂuid (an immunolog-
ically privileged site) for up to 3 years after
treatment. Therefore, removal of bacterial debris
from within the immunologically protected envi-
ronment of a healed vegetation, in which it is
known that antibody penetration is limited [15],
may be a slow process.
The implications of these ﬁndings for the
patient are at present unclear. It is unlikely that
the bacterial DNA detected within tissue indi-
cates the presence of viable microorganisms. If
bacteria are present, albeit in a non-culturable
Table 1. Patient details and PCR
resultsSex Age
Clinical
details
Description of
tissue at surgery
PCR result
(BlastN alignment similarity)
M 38 Culture-negative AV IE
3 months previously
Calciﬁc destruction of AV,
AVR with dense
adhesions, no active IE
Negative
M 73 Culture-negative AV
and MV IE
5 months previously
Previous infection Viridans Streptococcus
(99% 336 ⁄ 338 bp)
M 58 Staphylococcus aureus
AV IE
12 months previously
AV with defect,
deformity and ﬁbrosis
especially to a coronary cusp
Staphylococcus
(98% 298 ⁄ 304 bp)
M 62 Viridans Streptococcus
MV IE
18 months previously
Previous infection Viridans Streptococcus
(97% 314 ⁄ 323 bp)
M 66 Staphylococcus
epidermidis MV IE
2 years previously
P2 leaﬂet myxematous
with chordal rupture,
previous infection
Negative
F 70 Old AV IE, possibly
2.5 years previously
Bicuspid AV,
calciﬁc degeneration,
healed vegetation
Negative
M 91 Possible active IE; AV IE
5 years previously
Bicuspid AV,
no vegetation
Negative
F 36 Streptococcal AV IE
5 years previously
Healed vegetation
on non-coronary cusp
Negative
AV, aortic valve; MV, mitral valve; IE, infective endocarditis; AVR, aortic valve regurgitation.
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state, the patient is predisposed to recurrent
infection and current antimicrobial protocols for
the treatment of IE may need to be reviewed.
Alternatively, the bacterial DNA detected may
represent non-viable artefacts of the original
infection. The failure to detect microorganism
DNA within tissues removed several years after
infection supports this hypothesis. The persist-
ence of bacterial debris may be driving a con-
tinued sub-clinical immune response, leading to
further inﬂammation and damage to the valve. It
remains an intriguing possibility that a number
of patients, who have been treated successfully
for IE previously, may require surgical replace-
ment of a valve because of inﬂammatory damage
that has arisen from the persistence of bacterial
debris. These ﬁndings also have implications for
the diagnostic use of PCR in patients with a
history of previous infection.
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ABSTRACT
The in-vivo activity of colistin was evaluated in an
experimental rabbit model of Acinetobacter bau-
mannii endocarditis with a strain susceptible to
colistin and intermediate to imipenem. Compared
to a control group, colistin was effective (p < 0.05)
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